|
1
|
Matsuo K and Irie N: Osteoclast-osteoblast
communication. Arch Biochem Biophys. 473:201–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Riggs BL and Melton LJ III: The worldwide
problem of osteoporosis: Insights afforded by epidemiology. Bone.
17 (Suppl 5):505S–511S. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sözen T, Özışık L and Başaran NÇ: An
overview and management of osteoporosis. Eur J Rheumatol. 4:46–56.
2017. View Article : Google Scholar
|
|
4
|
Feng X and McDonald JM: Disorders of bone
remodeling. Annu Rev Pathol. 6:121–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tella SH and Gallagher JC: Prevention and
treatment of postmenopausal osteoporosis. J Steroid Biochem Mol
Biol. 142:155–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khosla S, Burr D, Cauley J, Dempster DW,
Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, et
al: Bisphosphonate-associated osteonecrosis of the jaw: Report of a
task force of the American society for bone and mineral research. J
Bone Miner Res. 22:1479–1491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wysowski DK: Reports of esophageal cancer
with oral bisphosphonate use. N Engl J Med. 360:89–90. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kennel KA and Drake MT: Adverse effects of
bisphosphonates: Implications for osteoporosis management. Mayo
Clin Proc. 84:632–638. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lenart BA, Lorich DG and Lane JM: Atypical
fractures of the femoral diaphysis in postmenopausal women taking
alendronate. N Engl J Med. 358:1304–1306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Manson JE, Hsia J, Johnson KC, Rossouw JE,
Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R,
et al: Estrogen plus progestin and the risk of coronary heart
disease. N Engl J Med. 349:523–534. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Collaborative Group On Epidemiological
Studies Of Ovarian Cancer, ; Beral V, Gaitskell K, Hermon C, Moser
K, Reeves G and Peto R: Menopausal hormone use and ovarian cancer
risk: Individual participant meta-analysis of 52 epidemiological
studies. Lancet. 385:1835–1842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Puhalla S, Bhattacharya S and Davidson NE:
Hormonal therapy in breast cancer: A model disease for the
personalization of cancer care. Mol Oncol. 6:222–236. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collin-Osdoby P, Yu X, Zheng H and Osdoby
P: RANKL-mediated osteoclast formation from murine RAW 264.7 cells.
Methods Mol Biol. 80:153–166. 2003.PubMed/NCBI
|
|
14
|
Suda T, Takahashi N, Udagawa N, Jimi E,
Gillespie MT and Martin TJ: Modulation of osteoclast
differentiation and function by the new members of the tumor
necrosis factor receptor and ligand families. Endocr Rev.
20:345–357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye H, Arron JR, Lamothe B, Cirilli M,
Kobayashi T, Shevde NK, Segal D, Dzivenu OK, Vologodskaia M, Yim M,
et al: Distinct molecular mechanism for initiating TRAF6
signalling. Nature. 418:443–447. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Galibert L, Tometsko ME, Anderson DM,
Cosman D and Dougall WC: The involvement of multiple tumor necrosis
factor receptor (TNFR)-associated factors in the signaling
mechanisms of receptor activator of NF-kappaB, a member of the TNFR
superfamily. J Biol Chem. 273:34120–34127. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roy A, Kim YB, Cho KH and Kim JH: Glucose
starvation-induced turnover of the yeast glucose transporter Hxt1.
Biochim Biophys Acta. 1840:2878–2885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takayanagi H, Kim S, Koga T, Nishina H,
Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al:
Induction and activation of the transcription factor NFATc1 (NFAT2)
integrate RANKL signaling in terminal differentiation of
osteoclasts. Dev Cell. 3:889–901. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arai A, Mizoguchi T, Harada S, Kobayashi
Y, Nakamichi Y, Yasuda H, Penninger JM, Yamada K, Udagawa N and
Takahashi N: Fos plays an essential role in the upregulation of
RANK expression in osteoclast precursors within the bone
microenvironment. J Cell Sci. 125:2910–2917. 2012.PubMed/NCBI
|
|
21
|
Perry LM and Metzger J: Medicinal plants
of east and southeast Asia: Attributed properties and uses.
Cambridge: MIT Press; 1980
|
|
22
|
Jeong YH, Oh YC, Cho WK, Lee B and Ma JY:
Anti-inflammatory effects of melandrii herba ethanol extract via
inhibition of NF-κB and MAPK signaling pathways and induction of
HO-1 in RAW 264.7 cells and mouse primary macrophages. Molecules.
21:8182016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Herbology editorial committee of Korean
medicine schools. Herbology. Seoul, . Yeonglimsa. 306–308.
2012.
|
|
24
|
Redlich K and Smolen JS: Inflammatory bone
loss: Pathogenesis and therapeutic intervention. Nat Rev Drug
Discov. 11:234–250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lacativa PG and Farias ML: Osteoporosis
and inflammation. Arq Bras Endocrinol Metabol. 54:123–132. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McLean RR: Proinflammatory cytokines and
osteoporosis. Curr Osteoporos Rep. 7:134–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ruscitti P, Cipriani P, Carubbi F,
Liakouli V, Zazzeroni F, Di Benedetto P, Berardicurti O, Alesse E
and Giacomelli R: The role of IL-1β in the bone loss during
rheumatic diseases. Mediators Inflamm. 2015:7823822015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang J, Jia Y, Lu X, Zhang T, Zhao K, Fu
Z, Pang C and Qian Y: Vitexin suppresses RANKL-induced
osteoclastogenesis and prevents lipopolysaccharide (LPS)-induced
osteolysis. J Cell Physiol. 234:17549–17560. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee MY, Shin IS, Seo CS, Lee NH, Ha HK,
Son JK and Shin HK: Effects of Melandrium firmum methanolic
extract on testosterone-induced benign prostatic hyperplasia in
Wistar rats. Asian J Androl. 14:320–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taciak B, Bialasek M, Braniewska A, Sas Z,
Sawicka P, Kiraga Ł, Rygiel T and Król M: Evaluation of phenotypic
and functional stability of RAW 264.7 cell line through serial
passages. PLoS One. 13:e01989432018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ballanti P, Minisola S, Pacitti MT,
Scarnecchia L, Rosso R, Mazzuoli GF and Bonucci E:
Tartrate-resistant acid phosphate activity as osteoclastic marker:
Sensitivity of cytochemical assessment and serum assay in
comparison with standardized osteoclast histomorphometry.
Osteoporos Int. 7:39–43. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tschöp MH, Speakman JR, Arch JR, Auwerx J,
Brüning JC, Chan L, Eckel RH, Farese RV Jr, Galgani JE, Hambly C,
et al: A guide to analysis of mouse energy metabolism. Nat Methods.
9:57–63. 2011. View Article : Google Scholar
|
|
33
|
Kim JH, Kim M, Jung HS and Sohn Y:
Leonurus sibiricus L. ethanol extract promotes osteoblast
differentiation and inhibits osteoclast formation. Int J Mol Med.
44:913–926. 2019.PubMed/NCBI
|
|
34
|
Kim M, Kim M, Kim JH, Hong S, Kim DH, Kim
S, Kim EY, Jung HS and Sohn Y: Crataegus pinnatifida bunge inhibits
RANKL-induced osteoclast differentiation in RAW 264.7 cells and
prevents bone loss in an ovariectomized rat model. Evid Based
Complement Alternat Med. 2021:55215622021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beconi MG, Howland D, Park L, Lyons K,
Giuliano J, Dominguez C, Munoz-Sanjuan I and Pacifici R:
Pharmacokinetics of memantine in rats and mice. PLoS Curr.
3:RRN12912011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jurdic P, Saltel F, Chabadel A and
Destaing O: Podosome and sealing zone: Specificity of the
osteoclast model. Eur J Cell Biol. 85:195–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao Q, Wang X, Liu Y, He A and Jia R:
NFATc1: Functions in osteoclasts. Int J Biochem Cell Biol.
42:576–579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grigoriadis AE, Wang ZQ, Cecchini MG,
Hofstetter W, Felix R, Fleisch HA and Wagner EF: c-Fos: A key
regulator of osteoclast-macrophage lineage determination and bone
remodeling. Science. 266:443–448. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim K, Lee SH, Ha Kim J, Choi Y and Kim N:
NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and
the dendritic cell-specific transmembrane protein (DC-STAMP). Mol
Endocrinol. 22:176–185. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sharp PE, La Regina MC and Suckow MA: The
laboratory rat. Boca Raton: CRC Press; 1998
|
|
41
|
Hansan KMM, Tamanna N and Haque MA:
Biochemical and histopathological profiling of Wistar rat treated
with Brassica napus as a supplementary feed. Food Sci Hum Well.
7:77–82. 2018. View Article : Google Scholar
|
|
42
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gregory CA, Gunn WG, Peister A and Prockop
DJ: An Alizarin red-based assay of mineralization by adherent cells
in culture: Comparison with cetylpyridinium chloride extraction.
Anal Biochem. 329:77–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hartley JW, Evans LH, Green KY, Naghashfar
Z, Macias AR, Zerfas PM and Ward JM: Expression of infectious
murine leukemia viruses by RAW264.7 cells, a potential complication
for studies with a widely used mouse macrophage cell line.
Retrovirology. 5:12008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Collin-Osdoby P and Osdoby P:
RANKL-mediated osteoclast formation from murine RAW 264.7 cells.
Methods Mol Biol. 816:187–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kirstein B, Chambers TJ and Fuller K:
Secretion of tartrate-resistant acid phosphatase by osteoclasts
correlates with resorptive behavior. J Cell Biochem. 98:1085–1094.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hayman AR: Tartrate-resistant acid
phosphatase (TRAP) and the osteoclast/immune cell dichotomy.
Autoimmunity. 41:218–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Marchisio PC, Cirillo D, Naldini L,
Primavera MV, Teti A and Zambonin-Zallone A: Cell-substratum
interaction of cultured avian osteoclasts is mediated by specific
adhesion structures. J Cell Biol. 99:1696–1705. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hsu H, Lacey DL, Dunstan CR, Solovyev I,
Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, et
al: Tumor necrosis factor receptor family member RANK mediates
osteoclast differentiation and activation induced by
osteoprotegerin ligand. Proc Natl Acad Sci USA. 96:3540–3545. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jimi E, Akiyama S, Tsurukai T, Okahashi N,
Kobayashi K, Udagawa N, Nishihara T, Takahashi N and Suda T:
Osteoclast differentiation factor acts as a multifunctional
regulator in murine osteoclast differentiation and function. J
Immunol. 163:434–442. 1999.PubMed/NCBI
|
|
51
|
Naito A, Azuma S, Tanaka S, Miyazaki T,
Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T and
Inoue J: Severe osteopetrosis, defective interleukin-1 signalling
and lymph node organogenesis in TRAF6-deficient mice. Genes Cells.
4:353–362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wong BR, Josien R, Lee SY, Vologodskaia M,
Steinman RM and Choi Y: The TRAF family of signal transducers
mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem.
273:28355–28359. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yamashita T, Yao Z, Li F, Zhang Q, Badell
IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, et al:
NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB
ligand (RANKL) and tumor necrosis factor-induced osteoclast
precursor differentiation by activating c-Fos and NFATc1. J Biol
Chem. 282:18245–18253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ray N, Kuwahara M, Takada Y, Maruyama K,
Kawaguchi T, Tsubone H, Ishikawa H and Matsuo K: c-Fos suppresses
systemic inflammatory response to endotoxin. Int Immunol.
18:671–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fujioka S, Niu J, Schmidt C, Sclabas GM,
Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL and Chiao PJ:
NF-kappaB and AP-1 connection: Mechanism of NF-kappaB-dependent
regulation of AP-1 activity. Mol Cell Biol. 24:7806–7819. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Landström M: The TAK1-TRAF6 signalling
pathway. Int J Biochem Cell Biol. 42:585–589. 2010. View Article : Google Scholar
|
|
58
|
Wei ZF, Tong B, Xia YF, Lu Q, Chou GX,
Wang ZT and Dai Y: Norisoboldine suppresses osteoclast
differentiation through preventing the accumulation of TRAF6-TAK1
complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 pathways. PLoS
One. 8:e591712013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sundaram K, Nishimura R, Senn J, Youssef
RF, London SD and Reddy SV: RANK ligand signaling modulates the
matrix metalloproteinase-9 gene expression during osteoclast
differentiation. Exp Cell Res. 313:168–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Troen BR: The role of cathepsin K in
normal bone resorption. Drug News Perspect. 17:19–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
David JP, Rincon M, Neff L, Horne WC and
Baron R: Carbonic anhydrase II is an AP-1 target gene in
osteoclasts. J Cell Physiol. 188:89–97. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yagi M, Miyamoto T, Sawatani Y, Iwamoto K,
Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K,
et al: DC-STAMP is essential for cell-cell fusion in osteoclasts
and foreign body giant cells. J Exp Med. 202:345–351. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim
N, Kang JS, Miyamoto T, Suda T, Lee SK, et al: v-ATPase V0 subunit
d2-deficient mice exhibit impaired osteoclast fusion and increased
bone formation. Nat Med. 12:1403–1409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kim JH, Kim K, Jin HM, Youn BU, Song I,
Choi HS and Kim N: Upstream stimulatory factors regulate OSCAR gene
expression in RANKL-mediated osteoclast differentiation. J Mol
Biol. 383:502–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Miyazaki T, Tanaka S, Sanjay A and Baron
R: The role of c-Src kinase in the regulation of osteoclast
function. Mod Rheumatol. 16:68–74. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Nishikawa K, Nakashima T, Hayashi M,
Fukunaga T, Kato S, Kodama T, Takahashi S, Calame K and Takayanagi
H: Blimp1-mediated repression of negative regulators is required
for osteoclast differentiation. Proc Natl Acad Sci USA.
107:3117–3122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Miyauchi Y, Ninomiya K, Miyamoto H,
Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S,
Morioka H, et al: The Blimp1-Bcl6 axis is critical to regulate
osteoclast differentiation and bone homeostasis. J Exp Med.
207:751–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Eastell R, O'Neill TW, Hofbauer LC,
Langdahl B, Reid IR, Gold DT and Cummings SR: Postmenopausal
osteoporosis. Nat Rev Dis Primers. 2:160692016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Riggs BL, Khosla S and Melton LJ III: A
unitary model for involutional osteoporosis: Estrogen deficiency
causes both type I and II osteoporosis in postmenopausal women and
contributes to bone loss in aging men. J Bone Miner Res.
13:763–773. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kalu DN: The ovariectomized rat model of
postmenopausal bone loss. Bone Miner. 15:175–191. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kuo TR and Chen CH: Bone biomarker for the
clinical assessment of osteoporosis: Recent developments and future
perspectives. Biomark Res. 5(18)2017.PubMed/NCBI
|
|
72
|
Wu X, Xie CQ, Zhu QQ, Wang MY, Sun B,
Huang YP, Shen C, An MF, Zhao YL, Wang XJ and Sheng J: Green tea
(Camellia sinensis) aqueous extract alleviates
postmenopausal osteoporosis in ovariectomized rats and prevents
RANKL-induced osteoclastogenesis in vitro. Food Nutr Res. 62:2018.
View Article : Google Scholar
|
|
73
|
Ozer J, Ratner M, Shaw M, Bailey W and
Schomaker S: The current state of serum biomarkers of
hepatotoxicity. Toxicology. 245:194–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wronski TJ, Cintrón M and Dann LM:
Temporal relationship between bone loss and increased bone turnover
in ovariectomized rats. Calcif Tissue Int. 43:179–183. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ito M: Recent progress in bone imaging for
osteoporosis research. J Bone Miner Metab. 29:131–140. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Bouxsein ML, Boyd SK, Christiansen BA,
Guldberg RE, Jepsen KJ and Müller R: Guidelines for assessment of
bone microstructure in rodents using micro-computed tomography. J
Bone Miner Res. 25:1468–1486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Park SB, Lee YJ and Chung CK: Bone mineral
density changes after ovariectomy in rats as an osteopenic model:
Stepwise description of double dorso-lateral approach. J Korean
Neurosurg Soc. 48:309–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Parkinson IH and Fazzalari NL:
Interrelationships between structural parameters of cancellous bone
reveal accelerated structural change at low bone volume. J Bone
Miner Res. 18:2200–2205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Osterhoff G, Morgan EF, Shefelbine SJ,
Karim L, McNamara LM and Augat P: Bone mechanical properties and
changes with osteoporosis. Injury. 47 (Suppl 2):S11–S20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kim EY, Kim JH, Kim M, Park JH, Sohn Y and
Jung HS: Abeliophyllum distichum Nakai alleviates postmenopausal
osteoporosis in ovariectomized rats and prevents RANKL-induced
osteoclastogenesis in vitro. J Ethnopharmacol. 257:1128282020.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lee KY, Kim JH, Kim EY, Yeom M, Jung HS
and Sohn Y: Water extract of Cnidii Rhizoma suppresses
RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting
NFATc1/c-Fos signaling and prevents ovariectomized bone loss in
SD-rat. BMC Complement Altern Med. 19:2072019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kim M, Kim HS, Kim JH, Kim EY, Lee B, Lee
SY, Jun JY, Kim MB, Sohn Y and Jung HS: Chaenomelis fructus
inhibits osteoclast differentiation by suppressing NFATc1
expression and prevents ovariectomy-induced osteoporosis. BMC
Complement Med Ther. 20:352020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kim JH, Kim EY, Lee B, Min JH, Song DU,
Lim JM, Eom JW, Yeom M, Jung HS and Sohn Y: The effects of lycii
radicis cortex on RANKL-induced osteoclast differentiation and
activation in RAW 264.7 cells. Int J Mol Med. 37:649–658. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wang J, Fu B, Lu F, Hu X, Tang J and Huang
L: Inhibitory activity of linarin on osteoclastogenesis through
receptor activator of nuclear factor kappaB ligand-induced
NF-kappaB pathway. Biochem Biophys Res Commun. 495:2133–2138. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Seo CS and Shin HK: Simultaneous
determination of the five marker compounds in melandriumfirmum
using high-performance liquid chromatography with photodiode-array
detection. Nat Prod Commun. 11:1667–1669. 2016.PubMed/NCBI
|
|
86
|
Li Y, Zhang J, Yan C, Chen Q, Xiang C,
Zhang Q, Wang X and Jiang K: β-Ecdysterone prevents LPS-induced
osteoclastogenesis by regulating NF-κB pathway in vitro. Res
Square. 2020.
|
|
87
|
Jiang C, Xiao F, Gu X, Zhai Z, Liu X, Wang
W, Tang T, Wang Y, Zhu Z, Dai K, et al: Inhibitory effects of
ursolic acid on osteoclastogenesis and titanium particle-induced
osteolysis are mediated primarily via suppression of NF-κB
signaling. Biochimie. 111:107–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
